Prostate Cancer - Results from #22780

PSA screening 2013 : Background and perspectives - Abstract July 9, 2013

Diffusion-weighted MRI and its role in prostate cancer - Abstract July 9, 2013

Hormonal therapy with external radiation therapy for metastatic spinal cord compression from newly diagnosed prostate cancer - Abstract July 9, 2013

Prostate cancer screening in BRCA and lynch syndrome mutation carriers - Abstract July 9, 2013

Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer - Abstract July 9, 2013

Nonhormone therapy for metastatic castration-resistant prostate cancer - Abstract July 9, 2013

Therapeutic vaccines and immunotherapy in castration-resistant prostate cancer - Abstract July 9, 2013

Prostate cancer: Interpretation of management guidelines - Abstract July 8, 2013

An assessment of the shared allelic architecture between type 2 diabetes and prostate cancer - Abstract July 8, 2013

Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin - Abstract July 8, 2013

Kinetics of testosterone recovery in clinically localized prostate cancer patients treated with radical prostatectomy and subsequent short-term adjuvant androgen deprivation therapy - Abstract July 8, 2013

Is small prostate volume a predictor of Gleason score upgrading after radical prostatectomy? - Abstract July 8, 2013

Robotic mechanical localization of prostate cancer correlates with magnetic resonance imaging scans - Abstract July 8, 2013

Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent prostate cancer foci - Abstract July 8, 2013

Defining the threshold for significant versus insignificant prostate cancer - Abstract July 8, 2013

Individualized image-based lymph node irradiation for prostate cancer - Abstract July 8, 2013

Chemotherapy in castrate-resistant metastatic prostate cancer - Abstract July 5, 2013

Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification - Abstract July 5, 2013

Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer - Abstract July 5, 2013

Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: Trends in the PSA era - Abstract July 5, 2013

Page 1140 of 1435